Financial Results : Jamjoom Pharma profit jumps 38% to SAR 289.1M in H1 2025; Q2 at SAR 132M

Jamjoom Pharma profit jumps 38% to SAR 289.1M in H1 2025; Q2 at SAR 132M

24/07/2025 Argaam Exclusive

View other reports

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) reported a net profit of SAR 289.1 million for the first six months of 2025, an increase of 38% from SAR 209.9 million in the year-earlier period, fueled by improved operating leverage, reduced finance costs, and profit share from the Algerian joint venture.


Financials (M)

Item 6m 2024 6m 2025 Change‬
Revenues 731.20 853.75 16.8 %
Gross Income 467.59 543.64 16.3 %
Operating Income 232.23 293.53 26.4 %
Net Income 209.92 289.06 37.7 %
Average Shares 70.00 70.00 -
Earnings Per Share before unusual items (Riyals) 3.00 4.13 37.7 %
EPS (Riyal) 3.00 4.13 37.7 %

Q2 revenue grew 16.8% year-on-year (YoY), backed by commercial, operational, and strategic pillars, in addition to the performance across core therapeutic areas and key geographies.



Current Quarter Comparison (M)

Compared With The
Item Q2 2024 Q2 2025 Change‬
Revenues 345.74 396.22 14.6 %
Gross Income 218.18 250.80 14.9 %
Operating Income 104.95 135.35 29.0 %
Net Income 106.95 132.02 23.4 %
Average Shares 70.00 70.00 -
Earnings Per Share before unusual items (Riyal) 1.53 1.89 23.4 %
EPS (Riyal) 1.53 1.89 23.4 %

Q2 2025 net profit rose 23% to SAR 132 million, compared to SAR 106.95 million in the year-earlier period.

 

On a sequential basis, net earnings declined 15.9% from SAR 157.03 million in Q1 2025.

 

Total shareholders’ equity, excluding minority interest, reached SAR 1.68 billion by June 30, 2025, compared to SAR 1.46 billion in the year-earlier period.

 

View More Financial Results

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.